Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OLR1 Antikörper (PE)

Dieses Anti-OLR1-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von OLR1 in IF (p). Geeignet für Human, Maus, Ratte, Rind (Kuh) und Schwein.
Produktnummer ABIN705231

Kurzübersicht für OLR1 Antikörper (PE) (ABIN705231)

Target

Alle OLR1 Antikörper anzeigen
OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))

Reaktivität

Human, Maus, Ratte, Rind (Kuh), Schwein

Wirt

  • 52
  • 31
  • 3
  • 2
  • 1
  • 1
Kaninchen

Klonalität

  • 58
  • 32
Polyklonal

Konjugat

  • 57
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser OLR1 Antikörper ist konjugiert mit PE

Applikation

  • 65
  • 35
  • 30
  • 27
  • 25
  • 22
  • 13
  • 13
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Spezifität

    Excitation / Emission Wavelengths: 565nm/578nm

    Kreuzreaktivität

    Ratte (Rattus), Schwein, Rind (Kuh)

    Aufreinigung

    purified by Protein A

    Immunogen

    KLH conjugated synthetic peptide derived from human sLOX 1

    Isotyp

    IgG
  • Kommentare

    Excitation / Emission wavelength: 496nm / 578nm

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 µg/µL

    Buffer

    Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 4 °C for 12 months

    Haltbarkeit

    12 months
  • Target

    OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))

    Andere Bezeichnung

    sLOX 1

    Hintergrund

    Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.

    Molekulargewicht

    31kDa

    Gen-ID

    4973
Sie sind hier:
Chat with us!